AAAAAA

   
Results: 1-8 |
Results: 8
ERYTHROPOIETIN TREATMENT UNDER POLYCHEMOTHERAPY IN PATIENTS WITH GYNECOLOGIC MALIGNANCIES - A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND PLACEBO-CONTROLLED MULTICENTER STUDY
Authors: KURZ C MARTH C WINDBICHLER G LAHOUSEN M MEDL M VAVRA N SEVELDA P
Citation: C. Kurz et al., ERYTHROPOIETIN TREATMENT UNDER POLYCHEMOTHERAPY IN PATIENTS WITH GYNECOLOGIC MALIGNANCIES - A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND PLACEBO-CONTROLLED MULTICENTER STUDY, Gynecologic oncology, 65(3), 1997, pp. 461-466
PARITY AS AN INDEPENDENT PROGNOSTIC FACTOR IN MALIGNANT MIXED MESODERMAL TUMORS OF THE ENDOMETRIUM
Authors: MARTH C WINDBICHLER G PETRU E DIRSCHLMAYER W OBERMAIR A CZERWENKA K MULLERHOLZNER E DAPUNT O
Citation: C. Marth et al., PARITY AS AN INDEPENDENT PROGNOSTIC FACTOR IN MALIGNANT MIXED MESODERMAL TUMORS OF THE ENDOMETRIUM, Gynecologic oncology, 64(1), 1997, pp. 121-125
CISPLATIN RESISTANCE IS ASSOCIATED WITH REDUCED INTERFERON-GAMMA-SENSITIVITY AND INCREASED HER-2 EXPRESSION IN CULTURED OVARIAN-CARCINOMA CELLS
Authors: MARTH C WIDSCHWENDTER M KAERN J JORGENSEN NP WINDBICHLER G ZEIMET AG TROPE C DAXENBICHLER G
Citation: C. Marth et al., CISPLATIN RESISTANCE IS ASSOCIATED WITH REDUCED INTERFERON-GAMMA-SENSITIVITY AND INCREASED HER-2 EXPRESSION IN CULTURED OVARIAN-CARCINOMA CELLS, British Journal of Cancer, 76(10), 1997, pp. 1328-1332
ASSESSMENT OF THE POSTMENOPAUSAL ENDOMETR IUM BY TRANSVAGINAL SONOGRAPHY - A PROSPECTIVE-STUDY
Authors: VOLGGER B ALGE A WINDBICHLER G ZEIMET AG MULLERHOLZNER E MARTH C
Citation: B. Volgger et al., ASSESSMENT OF THE POSTMENOPAUSAL ENDOMETR IUM BY TRANSVAGINAL SONOGRAPHY - A PROSPECTIVE-STUDY, Gynakologisch-geburtshilfliche Rundschau, 36(1), 1996, pp. 21-28
INTERACTION OF RETINOIC ACID AND INTERFERON-ALPHA IN BREAST-CANCER CELL-LINES
Authors: WIDSCHWENDTER M DAXENBICHLER G BACHMAIR F MULLER E ZEIMET AG WINDBICHLER G UHLSTEIDL M LANG T MARTH C
Citation: M. Widschwendter et al., INTERACTION OF RETINOIC ACID AND INTERFERON-ALPHA IN BREAST-CANCER CELL-LINES, Anticancer research, 16(1), 1996, pp. 369-374
CIRCULATING IMMUNOSTIMULATORY PROTEIN 90K AND SOLUBLE INTERLEUKIN-2-RECEPTOR IN HUMAN OVARIAN-CANCER
Authors: ZEIMET AG NATOLI C HEROLD M FUCHS D WINDBICHLER G DAXENBICHLER G IACOBELLI S DAPUNT O MARTH C
Citation: Ag. Zeimet et al., CIRCULATING IMMUNOSTIMULATORY PROTEIN 90K AND SOLUBLE INTERLEUKIN-2-RECEPTOR IN HUMAN OVARIAN-CANCER, International journal of cancer, 68(1), 1996, pp. 34-38
DIFFERENT EFFECTS OF INTERFERONS, INTERLEUKIN-1-BETA AND TUMOR-NECROSIS-FACTOR-ALPHA IN NORMAL (OSE) AND MALIGNANT HUMAN OVARIAN EPITHELIAL-CELLS
Authors: MARTH C ZEIMET AG HEROLD M BRUMM C WINDBICHLER G MULLERHOLZNER E OFFNER F FEICHTINGER H ZWIERZINA H DAXENBICHLER G
Citation: C. Marth et al., DIFFERENT EFFECTS OF INTERFERONS, INTERLEUKIN-1-BETA AND TUMOR-NECROSIS-FACTOR-ALPHA IN NORMAL (OSE) AND MALIGNANT HUMAN OVARIAN EPITHELIAL-CELLS, International journal of cancer, 67(6), 1996, pp. 826-830
THE VALUE OF ETOPOSIDE (VP-16) AS SALVAGE THERAPY IN REFRACTORY OVARIAN-CANCER
Authors: MARTH C POINTNER E ZEIMET AG ABFALTER E KOZA A WINDBICHLER G HETZEL H DAPUNT O
Citation: C. Marth et al., THE VALUE OF ETOPOSIDE (VP-16) AS SALVAGE THERAPY IN REFRACTORY OVARIAN-CANCER, Geburtshilfe und Frauenheilkunde, 53(5), 1993, pp. 303-307
Risultati: 1-8 |